Allogeneic Cell Therapy Devices Market Size & Share, By Therapy Type (Stem Cell Therapies, Non-stem Cell Therapies), Therapeutic Area Hematological Disorders, Dermatological Disorders, Others) - Growth Trends, Regional Insights (U.S., Japan, South Korea, UK, Germany), Competitive Positioning, Global Forecast Report 2025-2034
Market Outlook
Market Size and Growth Outlook
Allogeneic Cell Therapy Devices Market size is anticipated to grow significantly, reaching USD 3.77 billion by 2034, up from USD 405.26 million. This growth represents a CAGR of over 25%, with a revenue forecast of USD 496.44 million for 2025.
Base Year Value (2024)
USD 405.26 million
CAGR (2025-2034)
25%
Forecast Year Value (2034)
USD 3.77 billion
Historical Data Period
2019-2024
Largest Region
North America
Forecast Period
2025-2034
Get more details on this report
Request Free Sample Report SNAPSHOT
Allogeneic Cell Therapy Devices Market Intelligence Snapshot
Regional Market Dynamics
Segment Momentum
Market Expansion Drivers
Leading Market Participants
FORECAST SNAPSHOT
Global Market Forecast Snapshot
Market Outlook
Regional and Segment Outlook
REGIONAL FORECAST
Regional Demand Dynamics
Largest Region
North America
75% Market Share in 2024
SEGMENT ANALYSIS
Segment Leadership and Growth Trends
Go beyond the chart, access full insights & data tables
Request Free Sample Report
Allogeneic Cell Therapy Devices Market Segment Analysis
By Therapy Type
The Allogeneic Cell Therapy Devices Market is categorized into two primary segments: Stem Cell Therapies and Non-stem Cell Therapies. Stem Cell Therapies hold a prominent position within the market due to their ability to generate a broad range of cell types and their application in regenerative medicine. Their use in treating various diseases, especially hematological disorders, contributes to their market growth. On the other hand, Non-stem Cell Therapies are gaining traction due to advancements in technologies and methods to create more targeted and efficient therapies. Both segments are witnessing innovations that enhance the safety and efficacy of treatments, ultimately driving market expansion.
By Therapeutic Area
The Allogeneic Cell Therapy Devices Market is also segmented by therapeutic area into Hematological Disorders, Dermatological Disorders, and Others. Hematological Disorders dominate the market as allogeneic cell therapies have shown substantial effectiveness in treating conditions such as leukemia and lymphoma. The continuous rise in the incidence of these disorders fuels the demand for innovative therapies. Dermatological Disorders represent a growing segment, particularly with advancements in cell-based therapies aimed at skin regeneration and treatment of chronic wounds. The “Others” segment includes various applications such as autoimmune diseases and organ transplantation, which are gradually emerging, showcasing the versatile potential of allogeneic cell therapies across different medical fields.
Competitive Landscape
Competitive Landscape and Market Positioning
The allogeneic cell therapy devices market is characterized by rapid growth and intense competition driven by advancements in biotechnology and regenerative medicine. Key players are increasingly focusing on innovative product development, strategic collaborations, and mergers and acquisitions to enhance their market presence. The demand for personalized medicine and high throughput manufacturing capabilities is pushing companies to invest in technologies that improve the efficiency and scalability of allogeneic cell therapies. Additionally, regulatory approvals and the integration of advanced manufacturing technologies such as automated cell processing and cryopreservation systems are shaping competitive dynamics. Companies are also emphasizing the development of robust supply chains to meet the growing need for therapeutic products across various regions.
Top Market Players
1. Novartis AG
2. Gilead Sciences, Inc.
3. Bristol-Myers Squibb Company
4. Celyad Oncology
5. Allogene Therapeutics, Inc.
6. Takeda Pharmaceutical Company
7. Maxcyte, Inc.
8. Fate Therapeutics, Inc.
9. bluebird bio, Inc.
10. Kite Pharma, Inc.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry News
Industry Development/News
| Company Name | Date | Key Development |
|---|
Report Customization
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Allogeneic Cell Therapy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Allogeneic Cell Therapy Devices Market — Custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom Research
Frequently Asked Questions
Testimonials
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
Quality Assurance Manager
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
R&D Manager
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
THIS REPORT'S RESEARCH VERTICAL
Research Team Overview
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Prepared by the Healthcare & Medical Devices Research Team
10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
Delivery
12k+
Research Reports
Published
Published
On-
Demand
Demand
Customized Research
Available
Available
6
Months Analyst
Support
Support
PDF + XLS
Report Deliverables
Trust & Compliance
☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling
Research Domains
10 coverage areas
Medical Devices & Equipment
Diagnostic Imaging
Clinical Diagnostics
Digital Health & Telemedicine
Patient Monitoring Systems
Surgical & Minimally Invasive Technologies
Healthcare IT & Data Systems
Biotechnology & Life Sciences
Pharmaceutical Technologies
Healthcare Delivery & Services
Research Intelligence
Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
01
Data Collection
Verified information gathered through primary and secondary research.
02
Data Triangulation
Cross-validation using multiple independent data sources.
03
Forecast Modelling
Market estimates developed using historical trends and analytical models.
04
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
05
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
06
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization
About This Report